Anacor Pharmaceuticals (ANAC) Stock Soars After Positive Late Stage Test Results

Shares of Anacor Pharmaceuticals Inc. (ANAC) were trading up +46.39 or +54.83 percent to $131.00 per share in premarket trading on Monday. The company announced early this morning that it had achieved preliminary top line results from two Phase 3 pivotal studies of the company's experimental topical lotion. Anacor Pharmaceuticals stock closed at $84.61 per ... READ MORE Read the rest of Anacor Pharmaceuticals (ANAC) Stock Soars After Positive Late Stage Test Results at InvestorGuide.com .